Catalan Institute of Oncology

Barcelona 08916

0 studies enrolling now · 7 studies all time

What they study most

Adenoid Cystic Carcinoma, Advanced Solid Tumor, Advanced Solid Tumors or Lymphomas, Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Breast Cancer, Colorectal Cancer, Combined Hepatocellular and Cholangiocarcinoma, Diffuse Large B Cell Lymphoma, Endometrial Cancer, Extranodal Extension, Glomus Tumor, Malignant, Head and Neck Squamous Cell Carcinoma

Studies at this site

• A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas — Recruiting now
• Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC). — Completed
• Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma — Running, not enrolling
• Ascertaining the Radiologic Prognostic Importance of Extranodal Extension on Imaging (iENE) in Head and Neck Cancer — Completed
• Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies — Stopped early
• Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma — Completed
• A Study of CA-170 (Oral PD-L1, PD-L2 and VISTA Checkpoint Antagonist) in Patients With Advanced Tumors and Lymphomas — Completed